Sankala Group’s Biohaven BHVN Stock Holding History

Sankala Group’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.77K	Hold	204	–	–	﹤0.01%	498
2025 Q4	$2.35K	Buy	+204	New	+$2.53K	﹤0.01%	487

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sankala Group's BHVN Position: Q1 2026 in Review

Sankala Group held its Biohaven (BHVN) position steady in Q1 2026 at 204 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Sankala Group first reported a position in BHVN in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.35K in Q4 2025. 276 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Sankala Group held 204 shares of Biohaven worth $1.77K as of Q1 2026.
Sankala Group left its Biohaven share count unchanged in Q1 2026.
Biohaven made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #498 holding.
Sankala Group first reported a position in Biohaven in Q4 2025 and has held it in 2 quarters since.
Sankala Group's Biohaven position peaked at $2.35K in Q4 2025.
276 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.